SOX2OT Variant 7 Contributes to the Synergistic Interaction Between EGCG and Doxorubicin to Kill Osteosarcoma via Autophagy and Stemness Inhibition
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-018-0689-3
Full Text
Open PDFAbstract
Available in full text
Date
February 23, 2018
Authors
Publisher
Springer Science and Business Media LLC